|
KIAA1737 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.26470000000268E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.828710E-04 |
| Normal-vs-Stage2 |
6.406600E-01 |
| Normal-vs-Stage3 |
1.20950000004338E-06 |
| Normal-vs-Stage4 |
1.40649999980091E-07 |
| Stage1-vs-Stage2 |
2.273700E-02 |
| Stage1-vs-Stage3 |
1.162400E-01 |
| Stage1-vs-Stage4 |
1.216130E-02 |
| Stage2-vs-Stage3 |
2.804600E-03 |
| Stage2-vs-Stage4 |
5.015200E-04 |
| Stage3-vs-Stage4 |
3.377400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55620000008972E-07 |
| Normal-vs-AfricanAmerican |
2.744500E-02 |
| Normal-vs-Asian |
1.199370E-04 |
| Caucasian-vs-AfricanAmerican |
3.234400E-01 |
| Caucasian-vs-Asian |
9.074800E-01 |
| AfricanAmerican-vs-Asian |
4.073400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.94539999999988E-05 |
| Normal-vs-Female |
1.407600E-04 |
| Male-vs-Female |
5.455200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.411000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.005920E-04 |
| Normal-vs-Age(61-80Yrs) |
1.017070E-03 |
| Normal-vs-Age(81-100Yrs) |
5.019600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.768000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.576800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.170400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.984600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.879600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.422800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.856100E-03 |
| Classical-VS-Follicular |
3.218400E-03 |
| Classical-VS-Other |
3.051800E-01 |
| Classical-VS-Normal |
1.51486999999673E-05 |
| Tall-VS-Follicular |
1.7418999999963E-05 |
| Tall-VS-Other |
9.988200E-01 |
| Tall-VS-Normal |
2.6759000015808E-08 |
| Follicular-VS-Other |
9.704200E-02 |
| Follicular-VS-Normal |
3.125600E-01 |
| Other-VS-Normal |
5.499200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.981100E-04 |
| Normal-vs-N1 |
7.9131999841664E-09 |
| N0-vs-N1 |
2.612500E-04 |
|
|
